BlackRock Investment Management’s Kindred Biosciences, Inc. KIN Stock Holding History

BlackRock Investment Management’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$13K	Hold	2,994	–	–	﹤0.01%	3521
2016 Q3	$15K	Hold	2,994	–	–	﹤0.01%	3450
2016 Q2	$11K	Buy	2,994 +736	+33%	+$2.71K	﹤0.01%	3610
2016 Q1	$8K	Hold	2,258	–	–	﹤0.01%	3711
2015 Q4	$8K	Hold	2,258	–	–	﹤0.01%	3765
2015 Q3	$12K	Hold	2,258	–	–	﹤0.01%	3627
2015 Q2	$15K	Sell	2,258 -27,566	-92%	-$196K	﹤0.01%	3565
2015 Q1	$213K	Sell	29,824 -748	-2%	-$5.16K	﹤0.01%	3207
2014 Q4	$228K	Hold	30,572	–	–	﹤0.01%	3237
2014 Q3	$283K	Sell	30,572 -104	-0.3%	-$1.41K	﹤0.01%	3185
2014 Q2	$572K	Buy	30,676 +9,204	+43%	+$156K	﹤0.01%	2971
2014 Q1	$398K	Buy	+21,472	New	+$409K	﹤0.01%	3064

Other funds holding KIN

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

BlackRock Investment Management's KIN Position: Q4 2016 in Review

BlackRock Investment Management held its Kindred Biosciences, Inc. (KIN) position steady in Q4 2016 at 2,994 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #3521.

BlackRock Investment Management first reported a position in KIN in Q1 2014 and has held it in 12 quarters since. The position peaked at $572K in Q2 2014. 43 funds tracked by Wall St. Rank hold KIN as of Q4 2016.

BlackRock Investment Management held 2,994 shares of Kindred Biosciences, Inc. worth $13K as of Q4 2016.
BlackRock Investment Management left its Kindred Biosciences, Inc. share count unchanged in Q4 2016.
Kindred Biosciences, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3521 holding.
BlackRock Investment Management first reported a position in Kindred Biosciences, Inc. in Q1 2014 and has held it in 12 quarters since.
BlackRock Investment Management's Kindred Biosciences, Inc. position peaked at $572K in Q2 2014.
43 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.